| Literature DB >> 19807415 |
Ivar Sønbø Kristiansen1, Tore Kristian Kvien.
Abstract
Cyclooxygenase-2 inhibitors exhibit the same effectiveness on rheumatic symptoms as nonsteroidal anti-inflammatory drugs, have fewer gastrointestinal side effects, but a higher price. Based on cost and healthcare utilization in Norway, this paper explores what factors are most important for the cost-effectiveness of cyclooxygenase-2 inhibitors and points to patient groups that may be most relevant for prescribing coxibs instead of nonsteroidal anti-inflammatory drugs.Entities:
Year: 2002 PMID： 19807415 DOI： 10.1586/14737167.2.3.229
Source DB: PubMed Journal: Expert Rev Pharmacoecon Outcomes Res ISSN： 1473-7167 Impact factor: 2.217